BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17073581)

  • 21. The important role of Bcrp (Abcg2) in the biliary excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in mice.
    Zamek-Gliszczynski MJ; Nezasa K; Tian X; Kalvass JC; Patel NJ; Raub TJ; Brouwer KL
    Mol Pharmacol; 2006 Dec; 70(6):2127-33. PubMed ID: 16959944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters.
    Lagas JS; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Mol Pharmacol; 2010 Apr; 77(4):687-94. PubMed ID: 20086033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig.
    Milne RW; Jensen RH; Larsen C; Evans AM; Nation RL
    Pharm Res; 1997 Aug; 14(8):1014-8. PubMed ID: 9279882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver.
    Ratna S; Chiba M; Bandyopadhyay L; Pang KS
    Hepatology; 1993 May; 17(5):838-53. PubMed ID: 8491453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatobiliary disposition of rhodamine 123 in isolated perfused rat livers.
    Parasrampuria R; Mehvar R
    Xenobiotica; 2008 Oct; 38(10):1263-73. PubMed ID: 18798123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver.
    Booth CL; Brouwer KR; Brouwer KL
    Cancer Res; 1998 Aug; 58(16):3641-8. PubMed ID: 9721873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species differences in the elimination of a peroxisome proliferator-activated receptor agonist highlighted by oxidative metabolism of its acyl glucuronide.
    Kochansky CJ; Xia YQ; Wang S; Cato B; Creighton M; Vincent SH; Franklin RB; Reed JR
    Drug Metab Dispos; 2005 Dec; 33(12):1894-904. PubMed ID: 16183782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biliary excretion of glycyrrhetinic acid: glucuronide-conjugate determination following a pharmacokinetic study of rat bile.
    Lu Y; Jing J; Ren W; Zhu J; Qiu Z; Li N; Li X; Zhao D; Parekh HS; Chen X
    Phytother Res; 2014 Dec; 28(12):1887-9. PubMed ID: 24849382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutathione conjugation and pharmacokinetics of 2-bromo-3-phenylpropionic acid in vitro and in the rat in vivo.
    Snel CA; Mahadevan S; Polhuijs M; Mulder GJ
    Chirality; 1992; 4(7):407-14. PubMed ID: 1361150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy.
    Walker GS; Atherton J; Bauman J; Kohl C; Lam W; Reily M; Lou Z; Mutlib A
    Chem Res Toxicol; 2007 Jun; 20(6):876-86. PubMed ID: 17536843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism and disposition of resveratrol in the isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
    Maier-Salamon A; Hagenauer B; Reznicek G; Szekeres T; Thalhammer T; Jäger W
    J Pharm Sci; 2008 Apr; 97(4):1615-28. PubMed ID: 17724663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretion of the organic anion harmol sulfate from liver into blood. Evidence for a carrier-mediated mechanism.
    de Vries MH; Groothuis GM; Mulder GJ; Nguyen H; Meijer DK
    Biochem Pharmacol; 1985 Jun; 34(12):2129-35. PubMed ID: 4004931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiological modeling of drug and metabolite: disposition of oxazepam and oxazepam glucuronides in the recirculating perfused mouse liver preparation.
    St-Pierre MV; van den Berg D; Pang KS
    J Pharmacokinet Biopharm; 1990 Oct; 18(5):423-48. PubMed ID: 2266497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation and protein binding of the acyl glucuronide of a leukotriene B4 antagonist (SB-209247): relation to species differences in hepatotoxicity.
    Kenny JR; Maggs JL; Tettey JN; Harrell AW; Parker SG; Clarke SE; Park BK
    Drug Metab Dispos; 2005 Feb; 33(2):271-81. PubMed ID: 15523047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Covalent binding of 2-phenylpropionyl-S-acyl-CoA thioester to tissue proteins in vitro.
    Li C; Olurinde MO; Hodges LM; Grillo MP; Benet LZ
    Drug Metab Dispos; 2003 Jun; 31(6):727-30. PubMed ID: 12756204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probenecid-associated alterations in valproate glucuronide hepatobiliary disposition: mechanistic assessment using mathematical modeling.
    Ward ES; Pollack GM; Brouwer KL
    J Pharmacol Exp Ther; 2001 Apr; 297(1):141-7. PubMed ID: 11259538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The disposition of morphine and its metabolites in the in-situ rat isolated perfused liver.
    Evans AM; Shanahan K
    J Pharm Pharmacol; 1995 Apr; 47(4):333-9. PubMed ID: 7791033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
    Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
    J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic analysis of hepatobiliary transport for conjugated metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugated hyperbilirubinemia.
    Takenaka O; Horie T; Kobayashi K; Suzuki H; Sugiyama Y
    Pharm Res; 1995 Nov; 12(11):1746-55. PubMed ID: 8592681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereoselective disposition of hydratropic acid in rat.
    Yamaguchi T; Nakamura Y
    Drug Metab Dispos; 1985; 13(5):614-9. PubMed ID: 2865113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.